English | Español

Arena Pharmaceuticals
Cheyenne Dickerson | May 21, 2017

Arena Pharmaceuticals preparing to present ralinepag drug Phase 1 results

Carol Ostrow | Feb 16, 2017

Arena presenting latest data on ulcerative colitis drug at summit
Carol Ostrow | Jan 13, 2017

Eisai acquires rights to Lorcaserin HCI for weight control
Jeff Gantt | Dec 24, 2016

ANVISA approves Belviq in Brazil
Carol Ostrow | Dec 16, 2016

Arena Pharmaceuticals plans Jan. 12 webcast, conference presentation

Jeff Gantt | Dec 14, 2016

Arena finalizes enrollment in ralinepag trial
Amanda Rupp | May 26, 2016

Arena Pharmaceuticals welcomes new president, CEO

Trending
Patient Daily | Dec 23, 2024

Patient Advocacy Group: ‘Policymakers must remove barriers to the development and delivery of innovative’ health care
+ Pharmaceuticals
Patient Daily | Dec 17, 2024

Arizona voters show strong support for clean energy transition